| Equol | Investigational | TFF1 | 7031 |
upregulated | Equol results in increased expression of TFF1 mRNA | 21q22.3 | |
| Equol | Investigational | THBS1 | 7057 |
downregulated | Equol results in decreased expression of THBS1 mRNA | 15q14 | |
| Equol | Investigational | UGT2B15 | 7366 |
upregulated | Equol results in increased expression of UGT2B15 mRNA | 4q13.2 | |
| Equol | Investigational | UGT2B17 | 7367 |
upregulated | Equol results in increased expression of UGT2B17 mRNA | 4q13.2 | |
| Erlotinib | Approved Investigational | BCL2 | 596 |
upregulated | Erlotinib Hydrochloride results in increased expression of BCL2 mRNA | 18q21.33 | |
| Erlotinib | Approved Investigational | BCL2L2 | 599 |
upregulated | Erlotinib Hydrochloride results in increased expression of BCL2L2 mRNA | 14q11.2 | |
| Erlotinib | Approved Investigational | CYP3A4 | 1576 |
upregulated | Erlotinib Hydrochloride results in increased expression of CYP3A4 mRNA | 7q22.1 | |
| Erlotinib | Approved Investigational | NOX4 | 50507 |
upregulated | Erlotinib Hydrochloride results in increased expression of and results in increased stability of NOX4 mRNA | 11q14.3 | |
| Erlotinib | Approved Investigational | ULBP1 | 80329 |
upregulated | Erlotinib Hydrochloride results in increased expression of ULBP1 mRNA | 6q25.1 | |
| Erythromycin | Approved Investigational Vet Approved | ASAH1 | 427 |
upregulated | Erythromycin results in increased expression of ASAH1 mRNA | 8p22 | |
| Erythromycin | Approved Investigational Vet Approved | ASNS | 440 |
downregulated | Erythromycin results in decreased expression of ASNS mRNA | 7q21.3 | |
| Erythromycin | Approved Investigational Vet Approved | CYP3A4 | 1576 |
upregulated | Erythromycin results in increased expression of CYP3A4 mRNA | 7q22.1 | |
| Erythromycin | Approved Investigational Vet Approved | FABP1 | 2168 |
upregulated | Erythromycin results in increased expression of FABP1 mRNA | 2p11.2 | |
| Erythromycin | Approved Investigational Vet Approved | FNDC4 | 64838 |
downregulated | Erythromycin results in decreased expression of FNDC4 mRNA | 2p23.3 | |
| Erythromycin | Approved Investigational Vet Approved | HPN | 3249 |
upregulated | Erythromycin results in increased expression of HPN mRNA | 19q13.11 | |
| Erythromycin | Approved Investigational Vet Approved | INHBE | 83729 |
upregulated | Erythromycin results in increased expression of INHBE mRNA | 12q13.3 | |
| Erythromycin | Approved Investigational Vet Approved | LSS | 4047 |
upregulated | Erythromycin results in increased expression of LSS mRNA | 21q22.3 | |
| Erythromycin | Approved Investigational Vet Approved | NUPR1 | 26471 |
downregulated | Erythromycin results in decreased expression of NUPR1 mRNA | 16p11.2 | |
| Erythromycin | Approved Investigational Vet Approved | NUPR1 | 26471 |
upregulated | Erythromycin results in increased expression of NUPR1 mRNA | 16p11.2 | |
| Erythromycin | Approved Investigational Vet Approved | TAGLN | 6876 |
downregulated | Erythromycin results in decreased expression of TAGLN mRNA | 11q23.2 | |
| Erythromycin | Approved Investigational Vet Approved | WIPI1 | 55062 |
upregulated | Erythromycin results in increased expression of WIPI1 mRNA | 17q24.2 | |
| Esomeprazole | Approved Investigational | CYP1A1 | 1543 |
upregulated | Esomeprazole results in increased expression of CYP1A1 mRNA | 15q24.1 | |
| Estriol | Approved Investigational Vet Approved | ABCB1 | 5243 |
upregulated | Estriol results in increased expression of ABCB1 mRNA | 7q21.12 | |
| Estriol | Approved Investigational Vet Approved | ABCG2 | 9429 |
upregulated | Estriol results in increased expression of ABCG2 mRNA | 4q22.1 | |
| Estriol | Approved Investigational Vet Approved | AGTR1 | 185 |
downregulated | Estriol results in decreased expression of AGTR1 mRNA | 3q24 | |